Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Annals of Surgical Oncology|July 2, 2009
Desmoid-type fibromatosis: a front-line conservative approach to select patients for surgical treatmentMarco Fiore, Françoise Rimareix, Luigi Mariani, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 19, 2019
Cost-Effectiveness of Web-Based Patient-Reported Outcome Surveillance in Patients With Lung CancerThibaut Lizée, Ethan Basch, Pierre Trémolières, et al.
Neuro-Oncology|December 21, 2014
Imaging of gliomas at 1.5 and 3 Tesla - A comparative studyLambros Tselikas, Raphaëlle Souillard-Scemama, Olivier Naggara, et al.
European Journal of Cancer (Oxford, England : 1990)|March 10, 2010
Phase II study of oral masitinib mesilate in imatinib-naïve patients with locally advanced or metastatic gastro-intestinal stromal tumour (GIST)Axel Le Cesne, Jean-Yves Blay, Binh Nguyen Bui, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 11, 2010
Genomic index of sensitivity to endocrine therapy for breast cancerW Fraser Symmans, Christos Hatzis, Christos Sotiriou, et al.
Cancer|August 6, 2013
CTNNB1 45F mutation is a molecular prognosticator of increased postoperative primary desmoid tumor recurrence: an independent, multicenter validation studyChiara Colombo, Rosalba Miceli, Alexander J Lazar, et al.
Neuro-Oncology Practice|March 20, 2025
Health-related quality of life in patients with progressive glioblastoma treated with combined bevacizumab and lomustine versus lomustine only: Secondary outcome of the randomized phase III EORTC 26101 studyLinda Dirven, Abigirl Machingura, Martin J van den Bent, et al.
The Lancet. Oncology|November 6, 2012
Lapatinib plus capecitabine in patients with previously untreated brain metastases from HER2-positive metastatic breast cancer (LANDSCAPE): a single-group phase 2 studyThomas Bachelot, Gilles Romieu, Mario Campone, et al.
British Journal of Neurosurgery|March 1, 2015
Combining intraoperative carmustine wafers and Stupp regimen in multimodal first-line treatment of primary glioblastomasVladislav Pavlov, Philippe Page, Georges Abi-Lahoud, et al.
European Journal of Cancer (Oxford, England : 1990)|December 22, 2015
Long-term outcome of molecular subgroups of GIST patients treated with standard-dose imatinib in the BFR14 trial of the French Sarcoma GroupAnna Patrikidou, Julien Domont, Sylvie Chabaud, et al.
Pageof 4